Panaji Journal

Propelled at 3.80% CAGR between 2020 and 2027, Global Acne Medication Market to Reach US$13.35 mn by 2027

 Breaking News
  • No posts were found

Propelled at 3.80% CAGR between 2020 and 2027, Global Acne Medication Market to Reach US$13.35 mn by 2027

November 26
06:30 2020
Propelled at 3.80% CAGR between 2020 and 2027, Global Acne Medication Market to Reach US$13.35 mn by 2027
ACNE MEDICATION MARKET BY THERAPEUTIC CLASS (RETINOIDS, ANTIBIOTICS, SALICYLIC ACID, BENZOYL PEROXIDE, AND OTHERS), FORMULATION (TOPICAL MEDICATIONS AND ORAL MEDICATIONS), TYPE (PRESCRIPTION MEDICINES AND OVER-THE-COUNTER MEDICINES), ACNE TYPE (NON-INFLAMMATORY ACNE AND INFLAMMATORY ACNE), AND DISTRIBUTION CHANNEL (RETAIL STORES, PHARMACIES & DRUG STORES, AND E-COMMERCE): GLOBAL OPPORTUNITY ANALYSIS AND INDUSTRY FORECAST, 2019-2027

A new study by Report Ocean states that the global acne medication market is likely to register a high rise in the years to come. The study is titled “Acne Medication Market by Therapeutic Class (Retinoids, Antibiotics, Salicylic Acid, Benzoyl Peroxide, and Others), Formulation (Topical Medications and Oral Medications), Type (Prescription Medicines and Over-The-Counter Medicines), Acne Type (Non-Inflammatory Acne and Inflammatory Acne), and Distribution Channel (Retail Stores, Pharmacies & Drug Stores, and E-Commerce): Global Opportunity Analysis and Industry Forecast, 2019-2027.”

 GET SAMPLE COPY @ https://www.reportocean.com/industry-verticals/sample-request?report_id=AMR1253

According to the study, the global acne medication market reached a valuation of US$11.86 mn in 2019. Progressing at a CAGR of 3.80% during the period from 2020 to 2027, the market is likely to touch US$13.35 mn by the end of the forecast period. The increasing prevalence of acne, especially in the younger population, is fueling the demand for acne medication across the world. Going forward, the market is likely to be driven by the presence of a robust pipeline of acne treatments and medications, states the report.

Impact of Covid 19 on Global Acne Medication Market

With the focus shifted to the healthcare and pharmaceutical sectors, other industries have taken a backseat during the Coronavirus pandemic. The acne medication market, among others, has been significantly disturbed by this pandemic. The production of acne medication has been stopped completely. Investments in cosmetology have found their route towards Covid research and, consequently, research activities have witnessed a decline, impacting the market’s growth. However, post-pandemic, when things will get better, the focus is expected to shift again to cosmetology and cosmetics and the market will gradually gain from it, assert analysts.

Preference for Prescription Medicines to Increase

In this report, the global acne medication market has been evaluated on the basis of the therapeutic class, formulation, type, acne type, distribution channel, and the region. By therapeutic class, the market has been classified into retinoids, antibiotics, salicylic acid, benzoyl peroxide, and others. Topical retinoid and combination retinoid and oral retinoid (isotretinoin) are the main retinoid type available in this market. Topical antibiotics and combination antibiotics and oral antibiotics are prominent antibiotics sold in the market.

On the basis of formulation, the market has been bifurcated into topical medication and oral medication. Based on the type, the market has been classified into prescription medicine and over-the-counter (OTC) medicine. The OTC segment is leading the global market at present. However, with the increasing cases of side-effects cases, caused by OTC medicines, consumer preference is shifting towards prescription medicines, which is expected to boost the prescription segment in the years to come. By acne type, it has been fragmented into non-inflammatory and inflammatory acne. By distribution channel, it has been classified into retail store, pharmacy and drug store, and e-commerce. Region wise, it has been analyzed across North America, Europe, Asia Pacific, and LAMEA in this report.

Key Findings:

  • The OTC segment is leading the global market, at present.
  • Consumer preference is shifting towards prescription medicines, which is expected to boost the prescription segment in the years to come.

The global acne medication market is segmented into:

By Therapeutic Class

  • Retinoid
    • Topical Retinoid & Combination Retinoid
    • Oral Retinoid (Isotretinoin)
  • Antibiotic
    • Topical Antibiotic & Combination Antibiotics
    • Oral Antibiotics
  • Salicylic Acid
  • Benzoyl Peroxide
  • Others

By Formulation

  • Topical Medication
  • Oral Medication

By Type

  • Prescription Medicine
  • Over-the-counter (OTC) Medicine

By Acne Type

  • Inflammatory Acne
  • Non-inflammatory Acne

By Distribution Channel

  • Retail Store
  • Pharmacy & Drug Store
  • E-Commerce

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Indonesia
    • Rest of Asia Pacific
  • LAMEA
    • Latin America
    • Middle East
    • Africa

Companies Mentioned in the Report

  • Almirall SA.
  • Bausch Health Companies Inc.
  • GlaxoSmithKline Plc (GSK)
  • Johnson & Johnson
  • Galderma S.A
  • Mayne Pharma Group Limited
  • Mylan N.V.
  • Pfizer Inc.
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceutical Industries Ltd.

READ FULL REPORT @ https://www.reportocean.com/industry-verticals/sample-request?report_id=AMR1253

Media Contact
Company Name: Report Ocean
Contact Person: Nishi Sharma
Email: Send Email
Phone: +91-9997112116
Address:BSI Business Park,H-15, Sector-63, Noida
City: Noida
State: UP, 201301
Country: India
Website: www.reportocean.com

Related Articles